These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 30788916

  • 21. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Iqbal IG, Iqbal K.
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [Abstract] [Full Text] [Related]

  • 22. Analysis of motor function in 6-month-old male and female 3xTg-AD mice.
    Stover KR, Campbell MA, Van Winssen CM, Brown RE.
    Behav Brain Res; 2015 Mar 15; 281():16-23. PubMed ID: 25486177
    [Abstract] [Full Text] [Related]

  • 23. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL, Tung YC, Liu F, Gong CX, Iqbal K.
    Alzheimers Res Ther; 2017 Jan 10; 9(1):1. PubMed ID: 28073379
    [Abstract] [Full Text] [Related]

  • 24. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
    Tomasini MC, Borelli AC, Beggiato S, Ferraro L, Cassano T, Tanganelli S, Antonelli T.
    J Alzheimers Dis; 2015 Jan 10; 46(2):407-21. PubMed ID: 25765918
    [Abstract] [Full Text] [Related]

  • 25. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.
    Chigurupati S, Madan M, Okun E, Wei Z, Pattisapu JV, Mughal MR, Mattson MP, Chan SL.
    J Alzheimers Dis; 2011 Jan 10; 24(2):349-61. PubMed ID: 21258150
    [Abstract] [Full Text] [Related]

  • 26. In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.
    Snow WM, Dale R, O'Brien-Moran Z, Buist R, Peirson D, Martin M, Albensi BC.
    J Alzheimers Dis; 2017 Jan 10; 58(3):841-853. PubMed ID: 28505976
    [Abstract] [Full Text] [Related]

  • 27. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011 Jan 10; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 28. Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice.
    Baglietto-Vargas D, Chen Y, Suh D, Ager RR, Rodriguez-Ortiz CJ, Medeiros R, Myczek K, Green KN, Baram TZ, LaFerla FM.
    J Neurochem; 2015 Sep 10; 134(5):915-26. PubMed ID: 26077803
    [Abstract] [Full Text] [Related]

  • 29. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
    Guzmán-Ramos K, Moreno-Castilla P, Castro-Cruz M, McGaugh JL, Martínez-Coria H, LaFerla FM, Bermúdez-Rattoni F.
    Learn Mem; 2012 Sep 14; 19(10):453-60. PubMed ID: 22984283
    [Abstract] [Full Text] [Related]

  • 30. Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
    Bitto A, Giuliani D, Pallio G, Irrera N, Vandini E, Canalini F, Zaffe D, Ottani A, Minutoli L, Rinaldi M, Guarini S, Squadrito F, Altavilla D.
    Inflamm Res; 2017 May 14; 66(5):389-398. PubMed ID: 28238167
    [Abstract] [Full Text] [Related]

  • 31. Neurofibrillary tangles and plaques are not accompanied by white matter pathology in aged triple transgenic-Alzheimer disease mice.
    Kastyak-Ibrahim MZ, Di Curzio DL, Buist R, Herrera SL, Albensi BC, Del Bigio MR, Martin M.
    Magn Reson Imaging; 2013 Nov 14; 31(9):1515-21. PubMed ID: 23993791
    [Abstract] [Full Text] [Related]

  • 32. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.
    Orta-Salazar E, Aguilar-Vázquez A, Martínez-Coria H, Luquín-De Anda S, Rivera-Cervantes M, Beas-Zarate C, Feria-Velasco A, Díaz-Cintra S.
    Life Sci; 2014 Oct 29; 116(2):83-9. PubMed ID: 25261598
    [Abstract] [Full Text] [Related]

  • 33. Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways.
    Giuliani D, Bitto A, Galantucci M, Zaffe D, Ottani A, Irrera N, Neri L, Cavallini GM, Altavilla D, Botticelli AR, Squadrito F, Guarini S.
    Neurobiol Aging; 2014 Mar 29; 35(3):537-47. PubMed ID: 24094579
    [Abstract] [Full Text] [Related]

  • 34. Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease.
    Stover KR, Campbell MA, Van Winssen CM, Brown RE.
    Behav Brain Res; 2015 Aug 01; 289():29-38. PubMed ID: 25896362
    [Abstract] [Full Text] [Related]

  • 35. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, Calon F.
    Neuroscience; 2009 Mar 03; 159(1):296-307. PubMed ID: 19135506
    [Abstract] [Full Text] [Related]

  • 36. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM, Dodacki A, Alata W, Calon F, Nicolic S, Scherrmann JM, Farinotti R, Bourasset F.
    J Alzheimers Dis; 2016 Mar 03; 49(2):287-300. PubMed ID: 26484906
    [Abstract] [Full Text] [Related]

  • 37. Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease.
    Romano A, Pace L, Tempesta B, Lavecchia AM, Macheda T, Bedse G, Petrella A, Cifani C, Serviddio G, Vendemiale G, Gaetani S, Cassano T.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(4):. PubMed ID: 25609597
    [Abstract] [Full Text] [Related]

  • 38. GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg-AD mouse model through anti-aging effects.
    Park HH, Kwon HS, Lee KY, Kim YE, Son JW, Choi NY, Han MH, Park DW, Kim S, Koh SH.
    Aging (Albany NY); 2024 Jan 31; 16(3):1983-2004. PubMed ID: 38301041
    [Abstract] [Full Text] [Related]

  • 39. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Yuksel M, Biberoglu K, Onder S, Akbulut KG, Tacal O.
    Biochimie; 2018 Mar 31; 146():105-112. PubMed ID: 29248542
    [Abstract] [Full Text] [Related]

  • 40. High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer's disease.
    Noristani HN, Verkhratsky A, Rodríguez JJ.
    Aging Cell; 2012 Oct 31; 11(5):810-22. PubMed ID: 22702392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.